MIBITop 1 mg kit
for radiopharmaceutical preparation

Active substance: 1 mg [tetrakis(1-isocyanide-2-methoxy-2-methylpropy)copper(I)] tetrafluoroborate

Indications/Posology:

• Diagnosis of reduced coronary perfusion and myocardial infarction: 400 – 900 MBq

• Diagnosis of ischaemic heart disease:

Two-day protocol: 600 – 900 MBq
One-day protocol: 400 – 500 MBq

• Assessment of global ventricular function:

600 – 800 MBq injected as a bolus

• Scintimammography:

700 – 1000 MBq injected as a bolus

• Localisation of hyperfunctioning parathyroid tissue:

200 – 700 MBq injected as a bolus

Activity of sodium pertechnetate (99mTc) to use for reconstitution: maximum 15 GBq

Volume of sodium pertechnetate (99mTc) to use for reconstitution: 1-3 mL

Shelf life and storage of MIBITop kit: 24 months in refrigerator (2°C – 8°C)

Shelf life and storage of 99mTc-MIBITop, the radiolabelled injection: after radiolabelling 16 h, do not store above 25°C

Pack size: 6 vials/kit